Dongsung Pharmaceutical Rebates: FTC Review – 10 Years On

by Archynetys Economy Desk

Fairness will soon be imposed on Dongseong Pharmaceutical, which was subject to administrative action in 2014 on charges of providing bribes through CSOs.transactionIt is expected that the committee will decide whether to dispose of the matter.

Related Posts

Leave a Comment